Search details
1.
CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment.
Blood
; 143(17): 1738-1751, 2024 Apr 25.
Article
in English
| MEDLINE | ID: mdl-38215390
2.
How should childhood acute lymphoblastic leukemia relapses in low-income and middle-income countries be managed: The AHOPCA-ALL study group experience.
Cancer
; 129(5): 771-779, 2023 03 01.
Article
in English
| MEDLINE | ID: mdl-36504077
3.
Development and Initial Validation of the ONCOREUM Score to Differentiate Childhood Cancer with Arthropathy from Juvenile Idiopathic Arthritis.
J Pediatr
; 253: 219-224.e3, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36202241
4.
Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemia.
Haematologica
; 108(12): 3278-3286, 2023 Dec 01.
Article
in English
| MEDLINE | ID: mdl-37021527
5.
Precursor B-cell acute lymphoblastic leukaemia-a global view.
Br J Haematol
; 196(3): 530-547, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34931311
6.
Osteonecrosis in paediatric acute lymphoblastic leukaemia: Incidence, risk factors, radiological patterns and evolution in a single-centre cohort.
Br J Haematol
; 197(5): 602-608, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35362095
7.
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia.
Haematologica
; 107(1): 49-57, 2022 01 01.
Article
in English
| MEDLINE | ID: mdl-33299233
8.
Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trial.
Am J Hematol
; 96(3): 292-301, 2021 03 01.
Article
in English
| MEDLINE | ID: mdl-33284999
9.
Closing the circle for ETP ALL.
Blood
; 142(24): 2039-2040, 2023 12 14.
Article
in English
| MEDLINE | ID: mdl-38095922
10.
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols.
Haematologica
; 105(7): 1887-1894, 2020 07.
Article
in English
| MEDLINE | ID: mdl-31601692
11.
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study.
Haematologica
; 104(9): 1812-1821, 2019 09.
Article
in English
| MEDLINE | ID: mdl-30705097
12.
Flow-cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B-cell precursor acute lymphoblastic leukemia in trial AIEOP-BFM-ALL 2000.
Pediatr Blood Cancer
; 66(5): e27590, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30561169
13.
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols.
Br J Haematol
; 182(5): 705-711, 2018 09.
Article
in English
| MEDLINE | ID: mdl-29938780
14.
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants.
Blood
; 137(14): 1980-1984, 2021 04 08.
Article
in English
| MEDLINE | ID: mdl-33512459
15.
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000.
Blood
; 127(17): 2101-12, 2016 04 28.
Article
in English
| MEDLINE | ID: mdl-26888258
16.
Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies.
Haematologica
; 103(1): 107-115, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29079599
17.
Does the Y chromosome play a role for outcome in childhood acute lymphoblastic leukemia?
Cancer
; 128(9): 1727-1729, 2022 05 01.
Article
in English
| MEDLINE | ID: mdl-35201616
18.
The treatment of childhood acute lymphoblastic leukemia in Guatemala: Biologic features, treatment hurdles, and results.
Cancer
; 123(3): 436-448, 2017 02 01.
Article
in English
| MEDLINE | ID: mdl-27683100
19.
Are clinical pharmacology studies still needed in childhood acute lymphoblastic leukemia?
Haematologica
; 107(2): 356-357, 2022 02 01.
Article
in English
| MEDLINE | ID: mdl-34196170
20.
NUP214-ABL1 fusion in childhood T-ALL.
Pediatr Blood Cancer
; 69(9): e29643, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35253360